Southern California Psychiatric Society (SCPS) Psychopharmacology Update 2018

Southern California Psychiatric Society (SCPS) Psychopharmacology Update is organized by Southern California Psychiatric Society (SCPS) and will be held on Jan 27, 2018 at The Olympic Collection Banquet & Conference Center, Los Angeles, California, United States of America. This CME Conference has been approved for a maximum of 5 Hours Category 1 CME credits.

Course Description:
Once again, SCPS is honored to present a distinguished panel of experts to address topics of relevance and clinical importance for psychiatrists. The program begins with an update on existing evidence on the potential of cannabis to both help and harm patients with psychiatric disorders. We follow with a special presentation addressing the basic neuroscience of neurotransmitter neural networks, highlighting the serotonin network as a model. Following lunch, we will hear about ketamine as a potential new treatment for depressive symptoms in major depression and bipolar depression. The program concludes with an update on new pharmacological and psychosocial approaches for psychosis and tardive dyskinesia.

Conference Objectives are:
• An enhanced evidence-based understanding of the potential benefits and risks of cannabis for patients with psychiatric disorders.
• Knowledge of the latest theories pertaining to the basic neuroscience of neurotransmitter neural networks, drawing on the serotonin network.
• Understanding of the latest evidence-based thinking regarding the use of ketamine in the treatment of major depression and bipolar depression.
• Applicable knowledge regarding new pharmacological and psychosocial approaches for psychosis and tardive dyskinesias.

Additional details will be posted as soon as they are available.